Pharmaceutical dronedarone composition for parenteral...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/343 (2006.01) A61K 9/08 (2006.01) A61K 47/02 (2006.01) A61K 47/12 (2006.01) A61K 47/40 (2006.01)

Patent

CA 2427375

The invention concerns a pharmaceutical composition for parenteral administration, characterised in that it comprises: dronedarone or one of its pharmaceutically acceptable salts as active principle; a physiologically acceptable buffer solution capable of maintaining the pH of the composition between 3 and 5; a physiologically acceptable water-soluble .beta.-cyclodextrin derivative.

L'invention a pour objet une composition pharmaceutique pour administration parentérale, caractérisée en ce qu'elle comprend: la dronédarone ou un de ses sels pharmaceutiquement acceptables en tant que principe actif; une solution tampon physiologiquement acceptable capable de maintenir le pH de la composition entre 3 et 5; un dérivé hydrosoluble de .beta.-cyclodextrine physiologiquement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical dronedarone composition for parenteral... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical dronedarone composition for parenteral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dronedarone composition for parenteral... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1881360

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.